Human growth hormone response to levodopa. Relation to menopause, depression, and plasma dopa concentration.
After ingestion of 500 mg of levodopa, postmenopausal women had significantly diminished human growth hormone (HGH) responses (mean, 4.6 ng/ml), as compared with those of age-matched men (mean, 9.1 ng/ml; P smaller than .05). The differences between the groups were not related to plasma dopa concentrations. The HGH responses to levodopa of age-matched unipolar and bipolar depressed men, and of unipolar depressed postmenopausal women, did not differ significantly from their respective normal control groups. Depressive illness of these types does not appear to affect the HGH response to levodopa, once the effect of the menopause is taken into account.
D000328:Adult; D000367:Age Factors; D000368:Aged; D003863:Depression / Q000503:physiopathology*; D004295:Dihydroxyphenylalanine / Q000097:blood*; D005260:Female; D013006:Growth Hormone / Q000097:blood / Q000378:metabolism*; D006801:Humans; D007980:Levodopa / Q000494:pharmacology*; D008297:Male; D008593:Menopause; D008875:Middle Aged; D010902:Pituitary Gland / Q000378:metabolism* / Q000503:physiopathology; D012737:Sex Factors
D007980:Levodopa; D004295:Dihydroxyphenylalanine; D013006:Growth Hormone